| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, Emission-Computed | 124 | 2005 | 1122 | 4.550 |
Why?
|
| Positron-Emission Tomography | 32 | 2022 | 6483 | 1.920 |
Why?
|
| Imagination | 14 | 2005 | 226 | 1.270 |
Why?
|
| Coronary Circulation | 17 | 2020 | 1569 | 1.220 |
Why?
|
| Dopamine | 9 | 2018 | 1606 | 0.960 |
Why?
|
| Cerebrovascular Circulation | 49 | 2013 | 2726 | 0.950 |
Why?
|
| Myocardial Perfusion Imaging | 3 | 2020 | 575 | 0.940 |
Why?
|
| Radiopharmaceuticals | 15 | 2020 | 2650 | 0.920 |
Why?
|
| Pyridazines | 2 | 2017 | 201 | 0.860 |
Why?
|
| Rest | 5 | 2017 | 918 | 0.800 |
Why?
|
| Membrane Potential, Mitochondrial | 3 | 2021 | 295 | 0.750 |
Why?
|
| Coronary Vessels | 6 | 2020 | 3095 | 0.630 |
Why?
|
| Brain Mapping | 23 | 2018 | 6634 | 0.630 |
Why?
|
| Brain | 62 | 2020 | 27101 | 0.610 |
Why?
|
| Oxygen Radioisotopes | 16 | 2015 | 75 | 0.580 |
Why?
|
| Stress, Physiological | 2 | 2017 | 1403 | 0.570 |
Why?
|
| Image Processing, Computer-Assisted | 21 | 2020 | 8998 | 0.550 |
Why?
|
| Movement | 7 | 2019 | 1476 | 0.520 |
Why?
|
| Corpus Striatum | 4 | 2008 | 1235 | 0.450 |
Why?
|
| Pattern Recognition, Visual | 5 | 2005 | 824 | 0.410 |
Why?
|
| Deoxyglucose | 11 | 1997 | 333 | 0.390 |
Why?
|
| Kinetics | 24 | 2016 | 6370 | 0.390 |
Why?
|
| Myocardium | 17 | 2021 | 4724 | 0.380 |
Why?
|
| Carbon Radioisotopes | 18 | 2012 | 561 | 0.380 |
Why?
|
| Factor Analysis, Statistical | 1 | 2013 | 997 | 0.370 |
Why?
|
| Memory | 9 | 2008 | 2192 | 0.370 |
Why?
|
| Regional Blood Flow | 19 | 2020 | 1496 | 0.360 |
Why?
|
| Cocaine | 4 | 2012 | 958 | 0.350 |
Why?
|
| Heart | 16 | 2019 | 4403 | 0.340 |
Why?
|
| Swine | 7 | 2020 | 5907 | 0.330 |
Why?
|
| Prefrontal Cortex | 10 | 2018 | 2219 | 0.320 |
Why?
|
| Fluorine Radioisotopes | 13 | 1998 | 418 | 0.310 |
Why?
|
| Visual Cortex | 6 | 2001 | 1105 | 0.310 |
Why?
|
| Functional Laterality | 16 | 2008 | 2256 | 0.300 |
Why?
|
| Neostriatum | 4 | 2005 | 247 | 0.290 |
Why?
|
| Word Association Tests | 3 | 2003 | 52 | 0.290 |
Why?
|
| Pyrrolidines | 1 | 2009 | 338 | 0.280 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2020 | 20556 | 0.280 |
Why?
|
| Reaction Time | 9 | 2005 | 2087 | 0.280 |
Why?
|
| Mitochondria | 1 | 2020 | 3619 | 0.280 |
Why?
|
| Least-Squares Analysis | 3 | 2016 | 368 | 0.270 |
Why?
|
| Frontal Lobe | 13 | 2006 | 1418 | 0.270 |
Why?
|
| Mental Recall | 8 | 2005 | 1222 | 0.260 |
Why?
|
| Psychomotor Performance | 4 | 2003 | 1882 | 0.260 |
Why?
|
| Verbal Behavior | 5 | 2004 | 335 | 0.250 |
Why?
|
| Motor Skills | 2 | 2008 | 521 | 0.250 |
Why?
|
| Membrane Transport Proteins | 6 | 2001 | 1034 | 0.250 |
Why?
|
| Association Learning | 2 | 2003 | 222 | 0.240 |
Why?
|
| Fluorodeoxyglucose F18 | 17 | 2019 | 2008 | 0.240 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2009 | 3356 | 0.230 |
Why?
|
| Reward | 2 | 2018 | 971 | 0.230 |
Why?
|
| Learning | 3 | 2007 | 1740 | 0.230 |
Why?
|
| Phantoms, Imaging | 7 | 2019 | 2518 | 0.230 |
Why?
|
| Renal Circulation | 3 | 2002 | 291 | 0.220 |
Why?
|
| Algorithms | 13 | 2013 | 14018 | 0.220 |
Why?
|
| Neurotransmitter Agents | 2 | 2009 | 665 | 0.220 |
Why?
|
| Benzamides | 1 | 2009 | 1371 | 0.220 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 7 | 2018 | 415 | 0.210 |
Why?
|
| Pattern Recognition, Automated | 1 | 2009 | 994 | 0.200 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 3527 | 0.200 |
Why?
|
| Raclopride | 4 | 2013 | 101 | 0.200 |
Why?
|
| Brain Chemistry | 5 | 2013 | 960 | 0.200 |
Why?
|
| Adenosine | 7 | 2020 | 805 | 0.190 |
Why?
|
| Iodine Radioisotopes | 4 | 2002 | 1031 | 0.190 |
Why?
|
| Models, Neurological | 7 | 2013 | 1768 | 0.180 |
Why?
|
| Comprehension | 2 | 2003 | 620 | 0.180 |
Why?
|
| Microspheres | 3 | 2020 | 782 | 0.180 |
Why?
|
| Tropanes | 1 | 2000 | 48 | 0.180 |
Why?
|
| Bayes Theorem | 3 | 2016 | 2326 | 0.180 |
Why?
|
| Emotions | 6 | 2009 | 2740 | 0.170 |
Why?
|
| Computer Simulation | 6 | 2020 | 6233 | 0.170 |
Why?
|
| Radioactive Tracers | 4 | 2012 | 66 | 0.170 |
Why?
|
| Organophosphorus Compounds | 1 | 2021 | 206 | 0.170 |
Why?
|
| Membrane Glycoproteins | 6 | 2001 | 3688 | 0.170 |
Why?
|
| Nitrogen Isotopes | 1 | 2020 | 84 | 0.170 |
Why?
|
| Humans | 151 | 2021 | 760617 | 0.170 |
Why?
|
| Ammonia | 2 | 2020 | 237 | 0.170 |
Why?
|
| Reference Values | 10 | 2012 | 4919 | 0.170 |
Why?
|
| Models, Biological | 13 | 2016 | 9461 | 0.170 |
Why?
|
| Mitochondria, Heart | 5 | 2022 | 229 | 0.170 |
Why?
|
| Adult | 89 | 2018 | 220969 | 0.160 |
Why?
|
| Male | 115 | 2018 | 360358 | 0.160 |
Why?
|
| Dopamine Antagonists | 5 | 2013 | 288 | 0.160 |
Why?
|
| Hippocampus | 7 | 2004 | 3761 | 0.160 |
Why?
|
| Myocardial Ischemia | 8 | 2005 | 2110 | 0.160 |
Why?
|
| Recruitment, Neurophysiological | 1 | 1998 | 33 | 0.160 |
Why?
|
| Radiology Information Systems | 1 | 2003 | 529 | 0.150 |
Why?
|
| Muscle, Skeletal | 5 | 2015 | 4947 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2018 | 36402 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 6 | 2001 | 4408 | 0.150 |
Why?
|
| Animals | 57 | 2022 | 168201 | 0.150 |
Why?
|
| Feasibility Studies | 3 | 2020 | 5239 | 0.140 |
Why?
|
| Fleroxacin | 5 | 1996 | 13 | 0.140 |
Why?
|
| Auditory Pathways | 1 | 1999 | 237 | 0.140 |
Why?
|
| Water | 2 | 2002 | 1409 | 0.140 |
Why?
|
| Verbal Learning | 4 | 2002 | 463 | 0.140 |
Why?
|
| Membrane Potentials | 1 | 2020 | 1089 | 0.140 |
Why?
|
| Individuality | 1 | 2018 | 301 | 0.140 |
Why?
|
| Basal Ganglia | 2 | 2013 | 554 | 0.140 |
Why?
|
| Myocardial Contraction | 8 | 2002 | 1515 | 0.140 |
Why?
|
| Attention | 5 | 2001 | 2396 | 0.140 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 3 | 2000 | 1068 | 0.140 |
Why?
|
| Anger | 3 | 2006 | 406 | 0.140 |
Why?
|
| Carrier Proteins | 6 | 2001 | 4935 | 0.140 |
Why?
|
| Nerve Net | 3 | 2008 | 2290 | 0.130 |
Why?
|
| Biophysical Phenomena | 2 | 2016 | 319 | 0.130 |
Why?
|
| Language | 6 | 2003 | 1541 | 0.130 |
Why?
|
| Cluster Analysis | 2 | 2002 | 2700 | 0.130 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2003 | 1222 | 0.130 |
Why?
|
| Radioisotopes | 9 | 1986 | 499 | 0.130 |
Why?
|
| Gyrus Cinguli | 9 | 2003 | 1115 | 0.130 |
Why?
|
| Monte Carlo Method | 3 | 2016 | 1257 | 0.130 |
Why?
|
| Macaca mulatta | 7 | 2013 | 2328 | 0.130 |
Why?
|
| Reproducibility of Results | 7 | 2020 | 20074 | 0.120 |
Why?
|
| Receptors, Dopamine D1 | 3 | 2006 | 292 | 0.120 |
Why?
|
| Obsessive-Compulsive Disorder | 6 | 2006 | 1491 | 0.120 |
Why?
|
| Doxorubicin | 1 | 2022 | 2224 | 0.120 |
Why?
|
| Form Perception | 1 | 1996 | 175 | 0.120 |
Why?
|
| Rotation | 3 | 2003 | 517 | 0.120 |
Why?
|
| Tissue Distribution | 13 | 2009 | 2261 | 0.120 |
Why?
|
| Synaptic Transmission | 2 | 2020 | 1169 | 0.120 |
Why?
|
| Cerebral Cortex | 10 | 2001 | 5776 | 0.120 |
Why?
|
| Vasodilator Agents | 4 | 2005 | 973 | 0.120 |
Why?
|
| Cerebrovascular Disorders | 6 | 2004 | 1474 | 0.120 |
Why?
|
| Putamen | 2 | 2007 | 292 | 0.120 |
Why?
|
| Hand | 3 | 2003 | 902 | 0.120 |
Why?
|
| Oxygen Consumption | 8 | 2001 | 1866 | 0.120 |
Why?
|
| Motor Cortex | 2 | 2001 | 1007 | 0.120 |
Why?
|
| Artificial Intelligence | 1 | 2009 | 2574 | 0.110 |
Why?
|
| Artifacts | 5 | 2019 | 1910 | 0.110 |
Why?
|
| Brain Diseases | 1 | 2003 | 1545 | 0.110 |
Why?
|
| Software | 3 | 2003 | 4431 | 0.110 |
Why?
|
| Female | 72 | 2018 | 392148 | 0.110 |
Why?
|
| Markov Chains | 1 | 2016 | 965 | 0.110 |
Why?
|
| Neural Pathways | 4 | 2018 | 3056 | 0.100 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2013 | 108 | 0.100 |
Why?
|
| Visual Perception | 5 | 2001 | 1388 | 0.100 |
Why?
|
| Stress Disorders, Post-Traumatic | 7 | 2011 | 4575 | 0.100 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1999 | 1493 | 0.100 |
Why?
|
| Population | 1 | 2012 | 141 | 0.100 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2013 | 484 | 0.100 |
Why?
|
| Normal Distribution | 1 | 2012 | 272 | 0.090 |
Why?
|
| Photic Stimulation | 4 | 2005 | 1987 | 0.090 |
Why?
|
| Carbon Dioxide | 11 | 1999 | 1148 | 0.090 |
Why?
|
| Vietnam Conflict | 1 | 2011 | 101 | 0.090 |
Why?
|
| Robotics | 1 | 1998 | 816 | 0.090 |
Why?
|
| Rabbits | 13 | 2015 | 4770 | 0.090 |
Why?
|
| Anti-Infective Agents | 5 | 2002 | 983 | 0.090 |
Why?
|
| Blood Volume | 3 | 1992 | 547 | 0.090 |
Why?
|
| Radionuclide Imaging | 12 | 2001 | 1972 | 0.090 |
Why?
|
| Methionine | 4 | 2002 | 572 | 0.080 |
Why?
|
| Radiation Injuries | 1 | 1997 | 1189 | 0.080 |
Why?
|
| Caudate Nucleus | 3 | 2007 | 390 | 0.080 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 491 | 0.080 |
Why?
|
| Fluconazole | 4 | 1997 | 157 | 0.080 |
Why?
|
| Analysis of Variance | 6 | 2005 | 6224 | 0.080 |
Why?
|
| Dobutamine | 3 | 2000 | 116 | 0.080 |
Why?
|
| Schizophrenia | 4 | 2003 | 6929 | 0.080 |
Why?
|
| Hindlimb | 3 | 2002 | 513 | 0.080 |
Why?
|
| Receptors, Dopamine | 2 | 2008 | 296 | 0.080 |
Why?
|
| Sample Size | 1 | 2012 | 838 | 0.080 |
Why?
|
| Dopamine Agents | 2 | 2008 | 189 | 0.080 |
Why?
|
| Muscle Proteins | 3 | 1999 | 1152 | 0.080 |
Why?
|
| Meningioma | 1 | 1997 | 1215 | 0.080 |
Why?
|
| Technology, Radiologic | 1 | 1988 | 160 | 0.080 |
Why?
|
| Vasodilation | 2 | 2005 | 962 | 0.070 |
Why?
|
| Orientation | 2 | 2001 | 321 | 0.070 |
Why?
|
| Reading | 3 | 2003 | 531 | 0.070 |
Why?
|
| Aging | 4 | 2003 | 8699 | 0.070 |
Why?
|
| Acoustic Stimulation | 4 | 2001 | 1235 | 0.070 |
Why?
|
| Dogs | 12 | 2002 | 3838 | 0.070 |
Why?
|
| Dominance, Cerebral | 4 | 2006 | 623 | 0.070 |
Why?
|
| Glucose | 9 | 1997 | 4345 | 0.070 |
Why?
|
| Nuclear Medicine | 2 | 1984 | 237 | 0.070 |
Why?
|
| Amygdala | 3 | 2004 | 1353 | 0.070 |
Why?
|
| Adolescent | 17 | 2012 | 88234 | 0.070 |
Why?
|
| Blood Gas Analysis | 1 | 1988 | 379 | 0.070 |
Why?
|
| Auditory Perception | 2 | 2001 | 583 | 0.070 |
Why?
|
| Arousal | 3 | 2001 | 1171 | 0.070 |
Why?
|
| Presynaptic Terminals | 1 | 2008 | 302 | 0.060 |
Why?
|
| Benzazepines | 2 | 2006 | 310 | 0.060 |
Why?
|
| Heart Ventricles | 2 | 2017 | 3796 | 0.060 |
Why?
|
| Receptors, Drug | 1 | 2005 | 157 | 0.060 |
Why?
|
| Adrenergic beta-Agonists | 2 | 1997 | 346 | 0.060 |
Why?
|
| Piperazines | 3 | 2005 | 2521 | 0.060 |
Why?
|
| Child Abuse, Sexual | 2 | 1999 | 403 | 0.060 |
Why?
|
| Temporal Lobe | 3 | 2002 | 1695 | 0.060 |
Why?
|
| Abdomen | 1 | 2011 | 1128 | 0.060 |
Why?
|
| Internal Capsule | 1 | 2006 | 138 | 0.060 |
Why?
|
| Linear Models | 3 | 2003 | 5866 | 0.060 |
Why?
|
| Psycholinguistics | 1 | 2005 | 79 | 0.060 |
Why?
|
| False Positive Reactions | 1 | 2007 | 957 | 0.060 |
Why?
|
| Observer Variation | 2 | 2003 | 2606 | 0.060 |
Why?
|
| Citric Acid Cycle | 4 | 2002 | 231 | 0.060 |
Why?
|
| Models, Statistical | 1 | 1999 | 5073 | 0.060 |
Why?
|
| Middle Aged | 44 | 2012 | 220584 | 0.060 |
Why?
|
| Sensitivity and Specificity | 5 | 2009 | 14648 | 0.060 |
Why?
|
| Veterans | 2 | 2011 | 2649 | 0.060 |
Why?
|
| Radiographic Image Enhancement | 1 | 1988 | 876 | 0.060 |
Why?
|
| Computers | 2 | 1984 | 591 | 0.060 |
Why?
|
| MERRF Syndrome | 1 | 2003 | 4 | 0.060 |
Why?
|
| Mental Processes | 2 | 2003 | 243 | 0.060 |
Why?
|
| Radiotherapy, Conformal | 1 | 2007 | 548 | 0.050 |
Why?
|
| Semantics | 3 | 2003 | 612 | 0.050 |
Why?
|
| Oxygen | 9 | 1992 | 4226 | 0.050 |
Why?
|
| Telencephalon | 1 | 2003 | 141 | 0.050 |
Why?
|
| Mitochondrial Myopathies | 1 | 2003 | 50 | 0.050 |
Why?
|
| Antipsychotic Agents | 3 | 2005 | 3066 | 0.050 |
Why?
|
| Fluvoxamine | 1 | 2002 | 78 | 0.050 |
Why?
|
| Renal Plasma Flow, Effective | 1 | 2002 | 4 | 0.050 |
Why?
|
| Iodohippuric Acid | 1 | 2002 | 9 | 0.050 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2003 | 85 | 0.050 |
Why?
|
| Probenecid | 1 | 2002 | 73 | 0.050 |
Why?
|
| Kidney Cortex | 1 | 2002 | 169 | 0.050 |
Why?
|
| Hyperhomocysteinemia | 1 | 2002 | 118 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 2689 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2003 | 1141 | 0.050 |
Why?
|
| Scattering, Radiation | 2 | 2015 | 490 | 0.050 |
Why?
|
| Schizophrenic Psychology | 2 | 1999 | 1646 | 0.050 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2002 | 239 | 0.050 |
Why?
|
| Acidosis, Lactic | 1 | 2003 | 146 | 0.050 |
Why?
|
| Central Nervous System Agents | 2 | 2002 | 75 | 0.050 |
Why?
|
| Thalamus | 4 | 2004 | 1047 | 0.050 |
Why?
|
| Fingers | 1 | 2003 | 506 | 0.040 |
Why?
|
| Time Factors | 8 | 2012 | 39913 | 0.040 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2002 | 393 | 0.040 |
Why?
|
| Isotope Labeling | 4 | 1996 | 392 | 0.040 |
Why?
|
| Illusions | 1 | 2000 | 61 | 0.040 |
Why?
|
| Hypnosis | 1 | 2000 | 82 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2007 | 1269 | 0.040 |
Why?
|
| Guilt | 1 | 2000 | 95 | 0.040 |
Why?
|
| Escherichia coli Infections | 3 | 1993 | 518 | 0.040 |
Why?
|
| Judgment | 2 | 2000 | 272 | 0.040 |
Why?
|
| Kidney Function Tests | 1 | 2002 | 678 | 0.040 |
Why?
|
| Intracellular Membranes | 2 | 2002 | 389 | 0.040 |
Why?
|
| Discrimination Learning | 1 | 2001 | 278 | 0.040 |
Why?
|
| Motion Perception | 1 | 2003 | 374 | 0.040 |
Why?
|
| Saccades | 2 | 1998 | 234 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 1998 | 2495 | 0.040 |
Why?
|
| Fluoroquinolones | 2 | 1998 | 306 | 0.040 |
Why?
|
| Color Perception | 1 | 2000 | 213 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2005 | 1117 | 0.040 |
Why?
|
| Aggression | 2 | 2006 | 750 | 0.040 |
Why?
|
| Limbic System | 5 | 1999 | 419 | 0.040 |
Why?
|
| Pursuit, Smooth | 1 | 1998 | 38 | 0.040 |
Why?
|
| Libido | 1 | 1999 | 124 | 0.040 |
Why?
|
| Glutamic Acid | 4 | 1998 | 1175 | 0.040 |
Why?
|
| Nifedipine | 1 | 1999 | 221 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 2000 | 374 | 0.040 |
Why?
|
| Cardiotonic Agents | 2 | 2000 | 539 | 0.040 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 1998 | 21 | 0.040 |
Why?
|
| Thallium | 3 | 1983 | 100 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2022 | 678 | 0.040 |
Why?
|
| Deoxy Sugars | 3 | 1984 | 20 | 0.040 |
Why?
|
| Folic Acid | 1 | 2005 | 1323 | 0.040 |
Why?
|
| Memory Disorders | 2 | 2003 | 1197 | 0.040 |
Why?
|
| Image Enhancement | 1 | 2009 | 2881 | 0.040 |
Why?
|
| Ergolines | 1 | 1998 | 57 | 0.040 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2007 | 1655 | 0.040 |
Why?
|
| Collateral Circulation | 1 | 1999 | 293 | 0.040 |
Why?
|
| Behavior | 1 | 2001 | 540 | 0.040 |
Why?
|
| Parkinson Disease | 3 | 2000 | 2878 | 0.040 |
Why?
|
| Triglycerides | 1 | 2005 | 2459 | 0.040 |
Why?
|
| Protein Deficiency | 2 | 1988 | 59 | 0.040 |
Why?
|
| Deep Brain Stimulation | 1 | 2006 | 831 | 0.040 |
Why?
|
| Heart Rate | 8 | 2005 | 4180 | 0.040 |
Why?
|
| Aged | 23 | 2011 | 169042 | 0.040 |
Why?
|
| Naphthyridines | 1 | 1998 | 143 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 5 | 2002 | 3769 | 0.040 |
Why?
|
| Conditioning, Operant | 1 | 2018 | 309 | 0.040 |
Why?
|
| Brain Stem | 1 | 2002 | 858 | 0.040 |
Why?
|
| Serial Learning | 1 | 1997 | 42 | 0.040 |
Why?
|
| Blood Flow Velocity | 4 | 2005 | 1370 | 0.030 |
Why?
|
| Brain Ischemia | 3 | 2003 | 3028 | 0.030 |
Why?
|
| Nephrectomy | 1 | 2002 | 937 | 0.030 |
Why?
|
| Young Adult | 3 | 2018 | 59179 | 0.030 |
Why?
|
| Thigh | 2 | 2015 | 240 | 0.030 |
Why?
|
| Ligands | 3 | 2001 | 3268 | 0.030 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1976 | 71 | 0.030 |
Why?
|
| Models, Theoretical | 4 | 2002 | 3567 | 0.030 |
Why?
|
| Serotonin Antagonists | 1 | 1996 | 144 | 0.030 |
Why?
|
| Cholecystokinin | 1 | 1996 | 115 | 0.030 |
Why?
|
| Myocardial Infarction | 4 | 1996 | 11459 | 0.030 |
Why?
|
| Technetium | 3 | 1990 | 317 | 0.030 |
Why?
|
| Simvastatin | 1 | 1998 | 346 | 0.030 |
Why?
|
| Magnetics | 1 | 1999 | 597 | 0.030 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 1976 | 117 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 1997 | 9026 | 0.030 |
Why?
|
| Respiration | 3 | 2012 | 1656 | 0.030 |
Why?
|
| Receptors, Serotonin | 1 | 1996 | 208 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2003 | 5319 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 1998 | 412 | 0.030 |
Why?
|
| Anxiety Disorders | 2 | 1997 | 2723 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2011 | 4488 | 0.030 |
Why?
|
| Carbon Isotopes | 4 | 1997 | 458 | 0.030 |
Why?
|
| Electric Power Supplies | 1 | 2015 | 95 | 0.030 |
Why?
|
| Bronchitis | 1 | 1996 | 196 | 0.030 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2001 | 1191 | 0.030 |
Why?
|
| Auditory Cortex | 1 | 1999 | 363 | 0.030 |
Why?
|
| Half-Life | 3 | 1985 | 650 | 0.030 |
Why?
|
| Mathematics | 5 | 1997 | 707 | 0.030 |
Why?
|
| Problem Solving | 1 | 1997 | 444 | 0.030 |
Why?
|
| Biochemical Phenomena | 1 | 2015 | 58 | 0.030 |
Why?
|
| Eye Movements | 2 | 1996 | 511 | 0.030 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 1996 | 297 | 0.030 |
Why?
|
| Habituation, Psychophysiologic | 1 | 1995 | 147 | 0.030 |
Why?
|
| Neuropsychological Tests | 2 | 2005 | 7050 | 0.030 |
Why?
|
| Speech | 1 | 2000 | 555 | 0.030 |
Why?
|
| Cognition | 2 | 2003 | 6987 | 0.030 |
Why?
|
| Parietal Lobe | 1 | 2000 | 852 | 0.030 |
Why?
|
| Collagen | 3 | 1988 | 2634 | 0.030 |
Why?
|
| Rats, Inbred Strains | 7 | 1992 | 2088 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 1996 | 276 | 0.030 |
Why?
|
| Nitrogen Radioisotopes | 1 | 1994 | 41 | 0.030 |
Why?
|
| Electroencephalography | 1 | 1990 | 6237 | 0.030 |
Why?
|
| Online Systems | 1 | 1975 | 182 | 0.030 |
Why?
|
| Depression | 1 | 1994 | 8132 | 0.030 |
Why?
|
| Computer Systems | 1 | 1996 | 469 | 0.030 |
Why?
|
| Speech Perception | 1 | 1999 | 509 | 0.030 |
Why?
|
| Hypolipidemic Agents | 1 | 1998 | 609 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2006 | 8618 | 0.030 |
Why?
|
| Muscles | 2 | 1996 | 1573 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 1998 | 770 | 0.030 |
Why?
|
| Systole | 2 | 1999 | 935 | 0.030 |
Why?
|
| Thallium Radioisotopes | 1 | 1993 | 138 | 0.030 |
Why?
|
| Exercise | 1 | 1990 | 5886 | 0.030 |
Why?
|
| Visual Pathways | 1 | 1997 | 551 | 0.030 |
Why?
|
| Butyrates | 3 | 2002 | 169 | 0.030 |
Why?
|
| Rats | 13 | 2005 | 23717 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2022 | 1667 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 721 | 0.030 |
Why?
|
| Necrosis | 1 | 1997 | 1610 | 0.030 |
Why?
|
| Xenon Radioisotopes | 2 | 1987 | 33 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1996 | 563 | 0.030 |
Why?
|
| Conditioning, Classical | 1 | 1995 | 368 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2003 | 4910 | 0.030 |
Why?
|
| Fatty Acids | 2 | 1994 | 1808 | 0.030 |
Why?
|
| Extinction, Psychological | 1 | 1995 | 371 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 1996 | 763 | 0.030 |
Why?
|
| Phobic Disorders | 1 | 1995 | 439 | 0.020 |
Why?
|
| Anorexia Nervosa | 1 | 2001 | 1361 | 0.020 |
Why?
|
| Oxidation-Reduction | 4 | 2002 | 2231 | 0.020 |
Why?
|
| Abdominal Neoplasms | 1 | 1993 | 287 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2004 | 3735 | 0.020 |
Why?
|
| Pelvic Neoplasms | 1 | 1993 | 247 | 0.020 |
Why?
|
| Blood Pressure | 7 | 2005 | 8472 | 0.020 |
Why?
|
| Acetates | 3 | 1998 | 321 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2002 | 2090 | 0.020 |
Why?
|
| Safety | 1 | 2015 | 1149 | 0.020 |
Why?
|
| Radionuclide Ventriculography | 1 | 1990 | 40 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2001 | 2067 | 0.020 |
Why?
|
| Dopamine Agonists | 1 | 2013 | 352 | 0.020 |
Why?
|
| Stereotaxic Techniques | 2 | 2003 | 555 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 1997 | 1265 | 0.020 |
Why?
|
| Lung Neoplasms | 3 | 2003 | 13382 | 0.020 |
Why?
|
| Diagnosis, Differential | 3 | 2004 | 12966 | 0.020 |
Why?
|
| Depressive Disorder, Major | 2 | 2006 | 4764 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 1996 | 802 | 0.020 |
Why?
|
| Skin | 3 | 1988 | 4473 | 0.020 |
Why?
|
| Thiazoles | 1 | 1996 | 1517 | 0.020 |
Why?
|
| Candidiasis | 1 | 1991 | 365 | 0.020 |
Why?
|
| Myositis | 1 | 1992 | 270 | 0.020 |
Why?
|
| Cerebral Infarction | 1 | 1993 | 980 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 11116 | 0.020 |
Why?
|
| Homeostasis | 2 | 1998 | 3321 | 0.020 |
Why?
|
| Partial Pressure | 1 | 1988 | 245 | 0.020 |
Why?
|
| Radiography | 1 | 1999 | 6961 | 0.020 |
Why?
|
| Rubidium Radioisotopes | 1 | 1988 | 77 | 0.020 |
Why?
|
| Gated Blood-Pool Imaging | 1 | 1987 | 42 | 0.020 |
Why?
|
| Diastole | 1 | 1990 | 781 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2000 | 3182 | 0.020 |
Why?
|
| Cross-Over Studies | 2 | 2005 | 2079 | 0.020 |
Why?
|
| Captopril | 1 | 1988 | 265 | 0.020 |
Why?
|
| Coronary Disease | 3 | 1996 | 5912 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1996 | 2802 | 0.020 |
Why?
|
| Blood Glucose | 5 | 2005 | 6390 | 0.020 |
Why?
|
| Rubidium | 1 | 1986 | 122 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2002 | 4236 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 1994 | 1528 | 0.020 |
Why?
|
| Renal Artery Obstruction | 1 | 1988 | 219 | 0.020 |
Why?
|
| Electrocardiography | 2 | 2003 | 6346 | 0.020 |
Why?
|
| Plastics | 1 | 2007 | 117 | 0.020 |
Why?
|
| Chronic Disease | 3 | 2000 | 9311 | 0.020 |
Why?
|
| Double-Blind Method | 3 | 2005 | 12334 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1990 | 1597 | 0.020 |
Why?
|
| Hemodynamics | 3 | 2003 | 4160 | 0.020 |
Why?
|
| Blood Volume Determination | 1 | 1985 | 41 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1993 | 1372 | 0.020 |
Why?
|
| Posture | 1 | 1990 | 956 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2005 | 10754 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1976 | 1909 | 0.020 |
Why?
|
| Life Change Events | 2 | 2004 | 952 | 0.020 |
Why?
|
| Palmitates | 1 | 2005 | 70 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 6403 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 1997 | 8516 | 0.020 |
Why?
|
| Leg | 1 | 1990 | 1087 | 0.020 |
Why?
|
| Methylation | 2 | 1999 | 1077 | 0.020 |
Why?
|
| Capillaries | 1 | 1988 | 756 | 0.020 |
Why?
|
| Lung | 4 | 2011 | 9998 | 0.010 |
Why?
|
| Forecasting | 2 | 2002 | 2924 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 1996 | 2896 | 0.010 |
Why?
|
| Psychophysiology | 1 | 2004 | 135 | 0.010 |
Why?
|
| Pyrimidines | 1 | 1996 | 3027 | 0.010 |
Why?
|
| Research Design | 2 | 2004 | 6174 | 0.010 |
Why?
|
| Spleen | 1 | 1990 | 2286 | 0.010 |
Why?
|
| Models, Structural | 1 | 1984 | 340 | 0.010 |
Why?
|
| Subtraction Technique | 1 | 2007 | 512 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 4 | 1999 | 8166 | 0.010 |
Why?
|
| Neoplasms | 1 | 1993 | 22131 | 0.010 |
Why?
|
| Kidney | 2 | 1990 | 7045 | 0.010 |
Why?
|
| Nuclear Medicine Department, Hospital | 1 | 1983 | 13 | 0.010 |
Why?
|
| Parahippocampal Gyrus | 1 | 2004 | 115 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 18221 | 0.010 |
Why?
|
| Renin-Angiotensin System | 1 | 1988 | 737 | 0.010 |
Why?
|
| Vietnam | 1 | 2004 | 406 | 0.010 |
Why?
|
| Sulfones | 1 | 2005 | 447 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2005 | 509 | 0.010 |
Why?
|
| Hospital Departments | 1 | 1983 | 134 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1990 | 1779 | 0.010 |
Why?
|
| Metals | 1 | 2007 | 719 | 0.010 |
Why?
|
| Purines | 1 | 2005 | 606 | 0.010 |
Why?
|
| Catecholamines | 1 | 2003 | 387 | 0.010 |
Why?
|
| Fluorine | 4 | 1984 | 83 | 0.010 |
Why?
|
| Vocabulary | 1 | 2002 | 166 | 0.010 |
Why?
|
| Myocardial Reperfusion | 1 | 2003 | 338 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1974 | 2778 | 0.010 |
Why?
|
| Somatosensory Cortex | 2 | 1996 | 512 | 0.010 |
Why?
|
| Transportation | 1 | 1983 | 217 | 0.010 |
Why?
|
| Palmitic Acid | 1 | 2002 | 149 | 0.010 |
Why?
|
| Intestines | 1 | 1990 | 1909 | 0.010 |
Why?
|
| Stroke | 1 | 2003 | 9712 | 0.010 |
Why?
|
| Automation | 1 | 2003 | 585 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 2002 | 641 | 0.010 |
Why?
|
| Statistics as Topic | 2 | 2003 | 2358 | 0.010 |
Why?
|
| Models, Cardiovascular | 4 | 1989 | 981 | 0.010 |
Why?
|
| Amination | 1 | 1999 | 18 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1992 | 4533 | 0.010 |
Why?
|
| Amino Acids | 1 | 1985 | 1717 | 0.010 |
Why?
|
| Thyrotropin | 1 | 2003 | 834 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1999 | 189 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1999 | 343 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1999 | 366 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1997 | 9277 | 0.010 |
Why?
|
| Case-Control Studies | 3 | 2004 | 22148 | 0.010 |
Why?
|
| Atrophy | 1 | 2004 | 1631 | 0.010 |
Why?
|
| Transaminases | 1 | 1999 | 199 | 0.010 |
Why?
|
| Liver | 2 | 1993 | 7512 | 0.010 |
Why?
|
| Calcium Chloride | 1 | 1998 | 78 | 0.010 |
Why?
|
| Globus Pallidus | 1 | 1999 | 250 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2001 | 80566 | 0.010 |
Why?
|
| Radiochemistry | 1 | 1997 | 49 | 0.010 |
Why?
|
| Erythromycin | 1 | 1997 | 115 | 0.010 |
Why?
|
| Ketoglutaric Acids | 1 | 1998 | 76 | 0.010 |
Why?
|
| Oxygen Isotopes | 2 | 1988 | 43 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1993 | 4308 | 0.010 |
Why?
|
| Biological Availability | 1 | 1997 | 389 | 0.010 |
Why?
|
| MPTP Poisoning | 1 | 1996 | 37 | 0.010 |
Why?
|
| Syndrome | 1 | 2003 | 3268 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 1979 | 737 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2001 | 1813 | 0.010 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 1996 | 39 | 0.010 |
Why?
|
| Food | 1 | 2001 | 768 | 0.010 |
Why?
|
| Butyric Acid | 1 | 1995 | 51 | 0.010 |
Why?
|
| Acetic Acid | 1 | 1995 | 60 | 0.010 |
Why?
|
| Occupational Diseases | 1 | 2004 | 1490 | 0.010 |
Why?
|
| Lactates | 1 | 1996 | 404 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1996 | 573 | 0.010 |
Why?
|
| Lung Diseases, Obstructive | 1 | 1976 | 308 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2003 | 15828 | 0.010 |
Why?
|
| Pyridines | 1 | 1986 | 2874 | 0.010 |
Why?
|
| Biophysics | 1 | 1995 | 379 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1999 | 1200 | 0.010 |
Why?
|
| Pyrimidinones | 1 | 1996 | 385 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1995 | 414 | 0.010 |
Why?
|
| Heart Function Tests | 1 | 1974 | 318 | 0.010 |
Why?
|
| Energy Metabolism | 2 | 1996 | 2878 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 2003 | 58894 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 1993 | 6925 | 0.010 |
Why?
|
| Dipyridamole | 1 | 1993 | 140 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1993 | 213 | 0.010 |
Why?
|
| Arteries | 2 | 1988 | 1122 | 0.010 |
Why?
|
| Glycolysis | 1 | 1997 | 835 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2003 | 15251 | 0.010 |
Why?
|
| Cytosol | 1 | 1996 | 886 | 0.010 |
Why?
|
| Hemangioma, Cavernous | 1 | 1993 | 107 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2001 | 2241 | 0.010 |
Why?
|
| Space Perception | 1 | 1996 | 465 | 0.010 |
Why?
|
| Touch | 1 | 1995 | 309 | 0.010 |
Why?
|
| Energy Intake | 1 | 2000 | 2132 | 0.010 |
Why?
|
| Indium Radioisotopes | 1 | 1992 | 113 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1974 | 672 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 1997 | 960 | 0.010 |
Why?
|
| Drug Stability | 1 | 1991 | 291 | 0.010 |
Why?
|
| Ultrasonography | 2 | 2000 | 5964 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2004 | 2491 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1997 | 1988 | 0.010 |
Why?
|
| Perfusion | 1 | 1995 | 1373 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2003 | 64568 | 0.010 |
Why?
|
| Boston | 1 | 2003 | 9313 | 0.010 |
Why?
|
| United States | 2 | 2011 | 72272 | 0.010 |
Why?
|
| Cerebellum | 1 | 1996 | 1501 | 0.010 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1976 | 831 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1993 | 1540 | 0.010 |
Why?
|
| Wakefulness | 1 | 1996 | 1264 | 0.000 |
Why?
|
| Mice | 7 | 1993 | 81368 | 0.000 |
Why?
|
| Muscular Diseases | 1 | 1993 | 553 | 0.000 |
Why?
|
| Ventricular Function | 1 | 1990 | 406 | 0.000 |
Why?
|
| Hydroxyproline | 1 | 1988 | 110 | 0.000 |
Why?
|
| Methods | 1 | 1988 | 1065 | 0.000 |
Why?
|
| Species Specificity | 1 | 1992 | 2411 | 0.000 |
Why?
|
| Fasting | 1 | 1994 | 1603 | 0.000 |
Why?
|
| Lipids | 1 | 1998 | 3332 | 0.000 |
Why?
|
| Radiometry | 1 | 1993 | 812 | 0.000 |
Why?
|
| Child | 4 | 1999 | 80079 | 0.000 |
Why?
|
| Coronary Artery Bypass | 1 | 1996 | 2188 | 0.000 |
Why?
|
| Macaca nemestrina | 1 | 1986 | 21 | 0.000 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 1986 | 89 | 0.000 |
Why?
|
| Deuterium | 1 | 1986 | 106 | 0.000 |
Why?
|
| Metabolic Clearance Rate | 1 | 1987 | 361 | 0.000 |
Why?
|
| Vision Disorders | 1 | 1993 | 1088 | 0.000 |
Why?
|
| Ventricular Function, Left | 1 | 1999 | 3873 | 0.000 |
Why?
|
| Administration, Intranasal | 1 | 1987 | 476 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1996 | 2909 | 0.000 |
Why?
|
| Exercise Test | 1 | 1993 | 2127 | 0.000 |
Why?
|
| Acute Disease | 1 | 1996 | 7237 | 0.000 |
Why?
|
| Proline | 1 | 1986 | 455 | 0.000 |
Why?
|
| Comorbidity | 1 | 1999 | 10505 | 0.000 |
Why?
|
| Ischemic Attack, Transient | 1 | 1989 | 874 | 0.000 |
Why?
|
| Echocardiography | 1 | 1996 | 4987 | 0.000 |
Why?
|
| Tungsten | 1 | 1983 | 19 | 0.000 |
Why?
|
| Pulse | 1 | 1983 | 217 | 0.000 |
Why?
|
| Particle Accelerators | 1 | 1983 | 174 | 0.000 |
Why?
|
| Pulmonary Embolism | 1 | 1976 | 2568 | 0.000 |
Why?
|
| Radiation Dosage | 2 | 1981 | 1956 | 0.000 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1983 | 411 | 0.000 |
Why?
|
| Intracranial Embolism and Thrombosis | 1 | 1981 | 144 | 0.000 |
Why?
|
| Hematocrit | 1 | 1983 | 623 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2003 | 39063 | 0.000 |
Why?
|
| Postural Balance | 1 | 1985 | 622 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1993 | 2291 | 0.000 |
Why?
|
| Organ Culture Techniques | 1 | 1983 | 794 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2005 | 54360 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1983 | 1623 | 0.000 |
Why?
|
| Angina Pectoris, Variant | 1 | 1980 | 53 | 0.000 |
Why?
|
| Prostaglandins F | 1 | 1979 | 80 | 0.000 |
Why?
|
| Eating | 1 | 1987 | 1535 | 0.000 |
Why?
|
| Vascular Resistance | 1 | 1983 | 930 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2002 | 41457 | 0.000 |
Why?
|
| Haplorhini | 1 | 1980 | 525 | 0.000 |
Why?
|
| Insulin | 1 | 1994 | 6593 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 13635 | 0.000 |
Why?
|
| Physical Exertion | 1 | 1980 | 668 | 0.000 |
Why?
|
| Body Weight | 1 | 1987 | 4614 | 0.000 |
Why?
|
| Epinephrine | 1 | 1979 | 792 | 0.000 |
Why?
|
| Angina Pectoris | 1 | 1980 | 959 | 0.000 |
Why?
|
| Fetus | 1 | 1983 | 1862 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1981 | 3074 | 0.000 |
Why?
|
| Biological Transport | 1 | 1980 | 2089 | 0.000 |
Why?
|
| Carbon Monoxide | 1 | 1978 | 547 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1997 | 42188 | 0.000 |
Why?
|
| Stroke Volume | 1 | 1987 | 5486 | 0.000 |
Why?
|
| Pulmonary Artery | 1 | 1979 | 1927 | 0.000 |
Why?
|